Key New Studies in Gastric and Esophageal Cancer.
作者信息
Chang Daniel T, Jabbour Salma K, Brunner Thomas, Cheng Jason Chia-Hsien, Liauw Stanley L, Meyer Jeffrey, Wo Jennifer
出版信息
Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):475-81. doi: 10.1016/j.ijrobp.2015.05.045.
Abstract
摘要
相似文献
1
Key New Studies in Gastric and Esophageal Cancer.胃癌和食管癌的重要新研究。
Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):475-81. doi: 10.1016/j.ijrobp.2015.05.045.
2
Research progress on gut microbiota in patients with gastric cancer, esophageal cancer, and small intestine cancer.胃癌、食管癌和小肠癌患者肠道微生物组的研究进展。
Appl Microbiol Biotechnol. 2021 Jun;105(11):4415-4425. doi: 10.1007/s00253-021-11358-z. Epub 2021 May 26.
3
Application of Value Framework to Phase III Trials of Immune Checkpoint Inhibitors in Esophageal and Gastric Cancer.价值框架在食管和胃癌免疫检查点抑制剂 III 期试验中的应用。
Oncologist. 2023 Jan 18;28(1):40-47. doi: 10.1093/oncolo/oyac187.
4
An update of the WCRF/AICR systematic literature review on esophageal and gastric cancers and citrus fruits intake.世界癌症研究基金会/美国癌症研究所关于食管癌和胃癌与柑橘类水果摄入量的系统文献综述更新
Cancer Causes Control. 2016 Jul;27(7):837-51. doi: 10.1007/s10552-016-0755-0. Epub 2016 May 6.
5
Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population-based cohort studies in Japan.体质指数与食管癌和胃癌：日本 10 项基于人群队列研究的汇总分析。
Cancer Sci. 2023 Jul;114(7):2961-2972. doi: 10.1111/cas.15805. Epub 2023 May 10.
6
Treatment of esophageal-gastric double primary cancer by pedunculated remnant gastric interposition, esophageal-gastric anastomosis and gastrojejunal Billroth II anastomosis: A case report.带蒂残胃间置、食管胃吻合及胃空肠毕Ⅱ式吻合术治疗食管胃双原发癌：1例报告
Oncol Lett. 2015 Aug;10(2):891-894. doi: 10.3892/ol.2015.3301. Epub 2015 Jun 2.
7
Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis.双膦酸盐与食管癌和胃癌关联的证据：一项系统评价和荟萃分析。
BMJ Open. 2015 Dec 7;5(12):e007133. doi: 10.1136/bmjopen-2014-007133.
8
The impact of a healthy lifestyle on the risk of esophageal and gastric cancer subtypes.健康生活方式对食管和胃癌症亚型风险的影响。
Eur J Epidemiol. 2022 Sep;37(9):931-945. doi: 10.1007/s10654-022-00899-w. Epub 2022 Aug 19.
9
Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study.呋塞米在食管或胃癌患者中的使用与生存：一项基于人群的队列研究。
BMC Cancer. 2019 Oct 29;19(1):1017. doi: 10.1186/s12885-019-6242-8.
10
Sex-specific effects of fruit, vegetable, and red meat intake on the risk of gastric and esophageal cancer in a large cohort.水果、蔬菜和红肉摄入对大型队列中胃癌和食管癌风险的性别特异性影响。
Dig Liver Dis. 2023 Oct;55(10):1403-1410. doi: 10.1016/j.dld.2023.02.021. Epub 2023 Apr 8.
本文引用的文献
1
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.胃癌的分子分析确定了与不同临床结果相关的亚型。
Nat Med. 2015 May;21(5):449-56. doi: 10.1038/nm.3850. Epub 2015 Apr 20.
2
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.NEOSCOPE：一项随机II期研究，该研究采用诱导化疗，随后以奥沙利铂/卡培他滨或紫杉醇/卡铂为基础进行同步放化疗，作为可切除食管腺癌的术前治疗方案。
BMC Cancer. 2015 Feb 12;15:48. doi: 10.1186/s12885-015-1062-y.
3
Randomized trials and new directions in gastrointestinal cancer.胃肠道癌的随机试验与新方向
Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):459-64. doi: 10.1016/j.ijrobp.2014.10.015. Epub 2015 Jan 30.
4
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.比较卡培他滨和顺铂辅助化疗与同期放化疗治疗胃癌的 III 期临床试验：胃癌辅助放化疗临床试验的最终报告，包括生存和亚组分析。
J Clin Oncol. 2015 Oct 1;33(28):3130-6. doi: 10.1200/JCO.2014.58.3930. Epub 2015 Jan 5.
5
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.肝细胞癌患者肝功能评估：一种基于新证据的方法——ALBI分级
J Clin Oncol. 2015 Feb 20;33(6):550-8. doi: 10.1200/JCO.2014.57.9151. Epub 2014 Dec 15.
6
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.卡培他滨联合奥沙利铂辅助治疗 D2 胃切除术后胃癌（CLASSIC）：一项开放标签、随机、3 期临床试验的 5 年随访结果。
Lancet Oncol. 2014 Nov;15(12):1389-96. doi: 10.1016/S1470-2045(14)70473-5. Epub 2014 Oct 15.
7
Effect of high-dose stereotactic body radiation therapy on liver function in the treatment of primary and metastatic liver malignancies using the Child-Pugh score classification system.使用Child-Pugh评分分类系统，大剂量立体定向体部放射治疗对原发性和转移性肝脏恶性肿瘤治疗中肝功能的影响。
Pract Radiat Oncol. 2015 May-Jun;5(3):176-182. doi: 10.1016/j.prro.2014.09.007. Epub 2014 Nov 6.
8
Oncology scan-novel treatment strategies for gastrointestinal cancers.肿瘤学扫描——胃肠道癌症的新型治疗策略
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):699-703. doi: 10.1016/j.ijrobp.2014.01.048.
9
Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma.接受 Child-Pugh B 或 C 级肝癌立体定向体放射治疗的患者的治疗结果。
Radiother Oncol. 2014 Jun;111(3):412-7. doi: 10.1016/j.radonc.2014.05.002. Epub 2014 Jun 3.
10
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.含奥沙利铂 FOLFOX 方案与氟尿嘧啶和顺铂方案在食管癌患者中的确证放化疗比较（PRODIGE5/ACCORD17）：一项随机、2/3 期试验的最终结果。
Lancet Oncol. 2014 Mar;15(3):305-14. doi: 10.1016/S1470-2045(14)70028-2. Epub 2014 Feb 18.
Zotero 插件